CoDa Therapeutics

CoDa Therapeutics is a company focused on the development and commercialization of wound care therapeutics based on gap junction modulation.

CoDa Therapeutics is a San Diego-based pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. Its wound care technologies were developed initially through CoDaTherapeutics (NZ) Ltd., a New Zealand company formed by inventors Dr. Colin Green of the University of Auckland and Dr. David Becker of University College London. CoDaTherapeutics (NZ) Ltd., which has royalty rights and shareholding in CoDa Therapeutics, Inc., will continue research and will manage initial clinical trials in New Zealand in cooperation with the company.